Jun 05, 2018
7:5
For every 5 shares held, investors received 7. The price per share adjusted from $39.60 to $28.29.
The split itself did not change the total investment value.
Tasly Pharmaceutical Group Co. Ltd. Class A (SSE:600535) operates in the Pharmaceuticals: major industry.
Tasly Pharmaceutical Group Co. Ltd. Class A company overviewTasly Pharmaceutical Group Co. Ltd. Class A's most recent stock split was on June 5, 2018. It was a 7-for-5 forward split, so shareholders received 7 shares for every 5 they held.
Tasly Pharmaceutical Group Co. Ltd. Class A (SSE:600535) has split its stock 4 times: a 3-for-2 split on June 3, 2003, a 8-for-5 split on May 30, 2007, a 2-for-1 split on May 22, 2013, and a 7-for-5 split on June 5, 2018.
Tasly Pharmaceutical Group Co. Ltd. Class A has split its stock 4 times. This history records 4 forward splits between June 3, 2003 and June 5, 2018.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Tasly Pharmaceutical Group Co. Ltd. Class A's 7-for-5 split on June 5, 2018, every 5 shares became 7 shares.
Tasly Pharmaceutical Group Co. Ltd. Class A has not announced a new split in our records. Its most recent split was on June 5, 2018, 8 years ago. Companies announce splits in advance, and any new SSE:600535 split will appear on this page.
Already premium?